Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Current Leases (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Current Leases for 11 consecutive years, with $441000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 3.28% to $441000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $441000.0, a 3.28% increase, with the full-year FY2025 number at $441000.0, up 3.28% from a year prior.
  • Current Leases was $441000.0 for Q4 2025 at Ekso Bionics Holdings, down from $461000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $547000.0 in Q1 2021 to a low of $51000.0 in Q2 2022.
  • A 5-year average of $362700.0 and a median of $372000.0 in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: crashed 90.08% in 2022, then surged 601.96% in 2023.
  • Ekso Bionics Holdings' Current Leases stood at $229000.0 in 2021, then surged by 48.91% to $341000.0 in 2022, then increased by 6.45% to $363000.0 in 2023, then grew by 17.63% to $427000.0 in 2024, then increased by 3.28% to $441000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Current Leases are $441000.0 (Q4 2025), $461000.0 (Q3 2025), and $448000.0 (Q2 2025).